Einsiedel Lloyd, Spelman Tim, Goeman Emma, Cassar Olivier, Arundell Mick, Gessain Antoine
Flinders University/Northern Territory Rural Clinical School, Alice Springs Hospital, Alice Springs, Northern Territory, Australia ; SAPathology, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia.
Flinders University/Northern Territory Rural Clinical School, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
PLoS Negl Trop Dis. 2014 Jan 16;8(1):e2643. doi: 10.1371/journal.pntd.0002643. eCollection 2014.
In resource-poor areas, infectious diseases may be important causes of morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1). We report the clinical associations of HTLV-1 infection among socially disadvantaged Indigenous adults in central Australia.
HTLV-1 serological results for Indigenous adults admitted 1(st) January 2000 to 31(st) December 2010 were obtained from the Alice Springs Hospital pathology database. Infections, comorbid conditions and HTLV-1 related diseases were identified using ICD-10 AM discharge morbidity codes. Relevant pathology and imaging results were reviewed. Disease associations, admission rates and risk factors for death were compared according to HTLV-1 serostatus. HTLV-1 western blots were positive for 531 (33.3%) of 1595 Indigenous adults tested. Clinical associations of HTLV-1 infection included bronchiectasis (adjusted Risk Ratio, 1.35; 95% CI, 1.14-1.60), blood stream infections (BSI) with enteric organisms (aRR, 1.36; 95% CI, 1.05-1.77) and admission with strongyloidiasis (aRR 1.38; 95% CI, 1.16-1.64). After adjusting for covariates, HTLV-1 infection remained associated with increased numbers of BSI episodes (adjusted negative binomial regression, coefficient, 0.21; 95% CI, 0.02-0.41) and increased admission numbers with strongyloidiasis (coefficient, 0.563; 95% CI, 0.17-0.95) and respiratory conditions including asthma (coefficient, 0.99; 95% CI, 0.27-1.7), lower respiratory tract infections (coefficient, 0.19; 95% CI, 0.04-0.34) and bronchiectasis (coefficient, 0.60; 95% CI, 0.02-1.18). Two patients were admitted with adult T-cell Leukemia/Lymphoma, four with probable HTLV-1 associated myelopathy and another with infective dermatitis. Independent predictors of mortality included BSI with enteric organisms (aRR 1.78; 95% CI, 1.15-2.74) and bronchiectasis (aRR 2.07; 95% CI, 1.45-2.98).
HTLV-1 infection contributes to morbidity among socially disadvantaged Indigenous adults in central Australia. This is largely due to an increased risk of other infections and respiratory disease. The spectrum of HTLV-1 related diseases may vary according to the social circumstances of the affected population.
在资源匮乏地区,传染病可能是感染1型人类嗜T淋巴细胞病毒(HTLV - 1)个体发病的重要原因。我们报告了澳大利亚中部社会经济地位不利的原住民成年人中HTLV - 1感染的临床关联情况。
从爱丽丝泉医院病理数据库获取了2000年1月1日至2010年12月31日期间入院的原住民成年人的HTLV - 1血清学检测结果。使用国际疾病分类第十版澳大利亚修订本(ICD - 10 AM)出院发病编码来识别感染、合并症和HTLV - 1相关疾病。对相关病理和影像学结果进行了审查。根据HTLV - 1血清学状态比较了疾病关联、入院率和死亡风险因素。在接受检测的1595名原住民成年人中,531人(33.3%)的HTLV - 1免疫印迹法检测呈阳性。HTLV - 1感染的临床关联包括支气管扩张(校正风险比,1.35;95%置信区间,1.14 - 1.60)、肠道微生物引起的血流感染(BSI)(校正风险比,1.36;95%置信区间,1.05 - 1.77)以及因类圆线虫病入院(校正风险比1.38;95%置信区间,1.16 - 1.64)。在对协变量进行调整后,HTLV - 1感染仍与BSI发作次数增加(校正负二项回归,系数,0.21;95%置信区间,0.02 - 0.41)、因类圆线虫病入院次数增加(系数,0.563;95%置信区间,0.17 - 0.95)以及包括哮喘(系数,0.99;95%置信区间,0.27 - 1.7)、下呼吸道感染(系数,0.19;95%置信区间,0.04 - 0.34)和支气管扩张(系数,0.60;95%置信区间,0.02 - 1.18)在内的呼吸道疾病有关。两名患者因成人T细胞白血病/淋巴瘤入院,四名患者可能患有HTLV - 1相关脊髓病,另一名患者患有感染性皮炎。死亡的独立预测因素包括肠道微生物引起的BSI(校正风险比1.78;95%置信区间,1.15 - 2.74)和支气管扩张(校正风险比2.07;95%置信区间,1.45 - 2.98)。
HTLV - 1感染导致澳大利亚中部社会经济地位不利的原住民成年人发病。这主要是由于其他感染和呼吸道疾病风险增加。HTLV - 1相关疾病谱可能因受影响人群的社会环境而异。